Envoy Medical (COCH) Other Operating Expenses (2021 - 2026)

Envoy Medical (COCH) has 6 years of Other Operating Expenses data on file, last reported at -$7.1 million in Q1 2026.

• For the quarter ending Q1 2026, Other Operating Expenses fell 1319.69% year-over-year to -$7.1 million; the trailing twelve-month figure through Mar 2026 stood at -$3.3 million (down 668.15% YoY), and the FY2025 full-year result was $2.1 million, up 1933.01% from the prior year.
• Other Operating Expenses fell to -$7.1 million in Q1 2026, from $307000.0 in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $8.0 million in Q4 2023 to a low of -$7.1 million in Q1 2026.
• A 5-year average of $1.4 million and a median of $1.2 million in 2022 frame the typical range for Other Operating Expenses.
• Across the five-year window, Other Operating Expenses soared 1823.58% in 2023 and slumped 1319.69% in 2026, its largest moves.
• Tracing COCH's Other Operating Expenses over 5 years: stood at $5.1 million in 2022, then surged by 56.79% to $8.0 million in 2023, then tumbled by 98.72% to $103000.0 in 2024, then soared by 198.06% to $307000.0 in 2025, then sank by 2420.2% to -$7.1 million in 2026.
• Business Quant data shows COCH's Other Operating Expenses at -$7.1 million in Q1 2026, $307000.0 in Q4 2025, and $2.9 million in Q3 2025.